|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Oxcarbazepine Metabolite
Test CodeTRILE (Quest 36637Z)
Includes
10-Hydroxycarbazepine
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.25 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) tube
Transport Container
Plastic screw-cap vial
Transport Temperature
Room Temperature: 3 Days, Refrigerated: 2 Weeks, Frozen: 2 Months
Specimen Stability
Room temperature: 72 hours
Refrigerated: 14 days
Frozen: 60 days
Refrigerated: 14 days
Frozen: 60 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum Separator Tube (SST®)
Methodology
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat p.m.; Report available: 1-3 days
Reference Range
10-Hydroxycarbazepine | 8.0-35.0 mcg/mL |
Clinical Significance
Oxcarbazepine (10, 11-dihydro-10-oxo-5H-dibenz (bf) azepine-5-carboxamide, Trileptal), a 10-keto analogue of carbamazepine, is an anticonvulsant for the treatment of both generalized tonic-clonic and partial seizures in children and adults. It can be administered alone or as adjunct to other anticonvulsants. Clinically significant effects of oxcarbazepine are observed when plasma levels of its active metabolite, 10-OH-carbazepine, are between 15 and 35 ug/mL. Toxic symptoms may occur when plasma levels exceed 35 ug/mL.
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153